OsteoVantage was awarded a US $0.15MM Small Business Innovation and Research Phase I grant by the National Science Foundation. Funds will support enhancements to the INDOS™ spinal instrumentation system.
INDOS is designed to simultaneously enable stabilization of the spine and osteogenic stimulation of new bone formation/bony fusion. The present SBIR project will focus on development of electroactive pedicle screws that will stimulate the lateral gutter and zygapophyseal joints, thus encouraging posterolateral fusion.
Pilot animal studies indicate that INDOS may double rates of solid fusion in “hard-to-fuse” patients. OsteoVantage will initiate a further, comprehensive set of animal trials in 2016.
This represents the third NSF grant received by OsteoVantage, bringing the total awarded to $0.33MM from 2013 to the present.
OsteoVantage was awarded a US $0.15MM Small Business Innovation and Research Phase I grant by the National Science Foundation. Funds will support enhancements to the INDOS™ spinal instrumentation system.
INDOS is designed to simultaneously enable stabilization of the spine and osteogenic stimulation of new bone formation/bony fusion. The...
OsteoVantage was awarded a US $0.15MM Small Business Innovation and Research Phase I grant by the National Science Foundation. Funds will support enhancements to the INDOS™ spinal instrumentation system.
INDOS is designed to simultaneously enable stabilization of the spine and osteogenic stimulation of new bone formation/bony fusion. The present SBIR project will focus on development of electroactive pedicle screws that will stimulate the lateral gutter and zygapophyseal joints, thus encouraging posterolateral fusion.
Pilot animal studies indicate that INDOS may double rates of solid fusion in “hard-to-fuse” patients. OsteoVantage will initiate a further, comprehensive set of animal trials in 2016.
Copy to clipboard 
